ADMA BIOLOGICS, INC. Operating Leases, Future Minimum Payments, Due in Four Years
ADMA BIOLOGICS, INC. (ADMA) had Operating Leases, Future Minimum Payments, Due in Four Years of $1.26 million as of 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2021-05-12
- 2021-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.26M.
- 2020-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $871.53K.
- 2020-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $709.35K.
- 2020-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $706.92K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2021-03-31 | $1.26M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $871.53K 10-K · filed 2021-03-25 |
| 2020-09-30 | $709.35K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $706.92K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $461.85K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $360.20K 10-K · filed 2020-03-13 |
| 2019-09-30 | $382.29K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $382.29K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $379.97K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $340.85K 10-K · filed 2019-03-13 |
| 2017-12-31 | $670.81K 10-K · filed 2018-03-29 |
| 2016-12-31 | $376.81K 10-K · filed 2017-02-24 |
| 2015-12-31 | $375.20K 10-K · filed 2016-03-23 |
| 2014-12-31 | $356.77K 10-K · filed 2015-03-09 |
| 2013-12-31 | $353.06K 10-K · filed 2014-03-28 |
| 2012-12-31 | $168.09K 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |